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Background: Panax ginseng has a wide range of biological activities including anti-inﬂammatory, anti-
oxidant, and immunomodulatory functions. Wild ginseng cambial meristematic cells (CMCs) were ob-
tained from P. ginseng cambium. This study examined the protective mechanism of wild ginseng CMCs
against D-galactosamine (GalN)-induced liver injury. GalN, a well-known hepatotoxicant, causes severe
hepatocellular inﬂammatory damage and clinical features similar to those of human viral hepatitis in
experimental animals.
Methods: Hepatotoxicity was induced in rats using GalN (700 mg/kg, i.p.). Wild ginseng CMCs was
administered orally once a day for 2 wks, and then 2 h prior to and 6 h after GalN injection.
Results: Wild ginseng CMCs attenuated the increase in serum aminotransferase activity that occurs 24 h
after GalN injection. Wild ginseng CMCs also attenuated the GalN-induced increase in serum tumor
necrosis factor-a, interleukin-6 level, and hepatic cyclooxygenase-2 protein and mRNA expression. Wild
ginseng CMCs augmented the increase in serum interleukin -10 and hepatic heme oxygenase-1 protein
and mRNA expression that was induced by GalN, inhibited the increase in the nuclear level of nuclear
factor-kappa B, and enhanced the increase in NF-E2-related factor 2.
Conclusion: Our ﬁndings suggest that wild ginseng CMCs protects liver against GalN-induced inﬂam-
mation by suppressing proinﬂammatory mediators and enhancing production of anti-inﬂammatory
mediators.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hepatitis is a serious clinical problem caused by exposure to
different agents such as viruses, alcohol, and chemicals, and by
autoimmune diseases. Hepatitis may occur with limited or no
symptoms and often leads to anorexia, jaundice, and hepatic car-
cinoma [1]. Although extensive studies into the treatment of liver
diseasewith several oral hepatoprotective agents have been carried
out, few beneﬁcial liver drugs are currently available in the clinic. D-
Galactosamine (GalN) is a speciﬁc hepatotoxicant that depletes the
uridine triphosphate pool and thereby inhibits macromolecule
synthesis, inducing hepatotoxicity that resembles that of human
viral and drug-induced hepatitis [2]. In GalN-induced acute liveryunkwan University, 2066 Seobu-
ht  2015, The Korean Society of G
c-nd/4.0/).injury, overproduction of reactive oxygen species fromhepatocytes,
inﬁltrated leukocytes, and activated Kupffer cells, accompanied by
enhanced activity of the proinﬂammatory cytokine signaling
pathway, contributes to liver damage [3]. Heme oxygenase (HO)-1
is an endogenous cytoprotective enzyme induced in response to
cellular and environmental stresses. The critical role of HO-1 in the
protection against in vivo and in vitro inﬂammatory disease models
has been reported, and upregulation of HO-1 exerts an anti-
inﬂammatory effect in experimental settings of hepatic ischemia/
reperfusion and acute hepatitis [4].
Panax ginseng Meyer (Araliaceae) is a medicinal herb that has
been used worldwide for > 5,000 yrs. P. ginseng has been widely
used for treatment of inﬂammation, cardiovascular diseases,ro, Jangan-gu, Suwon-si, Gyeong gi-do, Korea.
inseng, Published by Elsevier Ltd. This is an open access article under the CC BY-NC-
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reported the biologic role of P. ginseng in experimental models of
liver diseases, including fatty liver disease, liver ﬁbrosis, hepatic
carcinoma, and chemical-induced liver injury [5]. Its biologic ac-
tivities are primarily attributable to ginsenosides, which produce
an array of pharmacologic responses [6]. Ginsenosides are located
in the root, leaf, seed, and ﬂower of P. ginseng, and have antitumor
and immunomodulatory activity in various organs [7]. However,
the yield of active components from natural sources can be highly
variable depending on the source plant, location, season of harvest,
and the prevailing environmental conditions [8]. In addition, a
dramatic depletion of the plant population has occurred as a result
of its consumption for medicinal purposes. The isolation of cambial
meristematic cells (CMCs) from selected P. ginseng species may
ensure a stable ginsenoside content and provide a sustainable
supply for therapeutic applications [9]. However, there are no re-
ports that demonstrate the biologic activity of natural compounds
isolated from wild ginseng CMCs.
The objective of this study is to investigate the cytoprotective
effects of wild ginseng CMCs against GalN-induced acute liver
injury, particularly the modulation of inﬂammatory responses.
2. Materials and methods
2.1. Materials/chemicals
The followings are the materials and chemicals we used in this
study: a 3-L bioreactor and a 20-L bioreactor (Samsung Science,
Seoul, Korea), a 250-L bioreactor (Fermentec Co. Ltd, Cheongwon,
Korea), 0.05% triﬂuoroacetic acid (Daejung Chemicals & Metals,
Siheung, Korea), ginsenoside 20(S)-Rg3 and ginsenoside 20(S)-Rh2
(Chromadex, Irvine, CA, USA), mixture of ginsenoside Rk1 and Rg5
(Ambo Institute, Seoul, Korea), acetonitrile (Merck, Darmstadt,
Germany), methanol (J.T. Baker, Center Valley, PA, USA), GalN and
silymarin (Sigma-Aldrich, St. Louis, MO, USA), alanine amino-
transferase (ALT) and aspartate aminotransferase (AST) assay kits
(IVDLab Co., Uiwang, Korea), tumor necrosis factor (TNF)-a, inter-
leukin (IL)-6 and IL-10 enzyme-linked immunosorbent assay kits
(BD Science, San Diego, CA, USA), PRO-PREP and enhanced chem-
iluminescence detection system (iNtRON Biotechnology, Seong-
nam, Korea), NE-PER and BCA Protein Assay Kits (Thermo Fisher
Scientiﬁc Inc., Rockford, IL, USA), polyvinylidene diﬂuoride mem-
brane (Millipore, Billerica, MA, USA), Semi-Dry Trans-Blot Cell (Bio-
Rad Laboratories, Hercules, CA, USA), RNAiso Plus and EcoDry cDNA
Synthesis Premix (Takara Bio Inc., Shiga, Japan), Thermocycler and
SYBR Green detection System (Roche Applied Science, Mannheim,
Germany). The following antibodies were used in this study:
cyclooxygenase-2 (COX-2; Cayman Chemicals, Ann Arbor, MI, USA),
HO-1 (Enzo Life Sciences, Farmingdale, NY, USA), kelch-like ECH-
associated protein 1 (Keap1) and lamin b1 (Abcam, Cambridge, MA,
USA), nuclear factor-kappa B (NF-kB)/p65, p-cJun and NF-E2-
related factor 2 (Nrf2; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), and b-actin (Sigma-Aldrich).
2.2. Plant cell culture
Wild ginseng CMCs were obtained from the cambium of
P. ginsengMeyer (wild ginseng; native to Kangwon province, Korea,
for > 50 yrs; appraised by the Korea Association of Wild Ginseng
Appraiser) [10]. Wild ginseng CMCs were gradually scaled up from
250-mL ﬂasks to a 3-L bioreactor, a 20-L bioreactor, and a 250-L
bioreactor. The bioreactors were all the airlift type. The working
volume of the 250-L bioreactor was 210 L, 84% of the total volume.
Wild ginseng CMCs were cultured in two stages: (1) a proliferation
stage to obtain biomass in the 250-L bioreactor and (2) a productionstage to obtain secondary metabolites such as ginsenosides. In
general, plant growth regulators, such as 2,4-dichlorophenoxyacetic
acid or naphthaleneacetic acid, are used to induce cell division.
However, to obtain biomass under the proliferation culture condi-
tion without using growth regulators, wild ginseng CMCs under-
went a cell habituation process for 1 yr without growth regulators
[9]. Wild ginseng CMCs obtained through this process were main-
tained for 37 mo. Culture conditions for the proliferation stage to
obtain biomass of wild ginseng CMCs were Murashige and Skoog
medium (MSmedium) containing 3% sucrose, pH 5.8, cell inoculum
of 2.09 g/L [dry cell weight (DCW)], and aeration rate of 0.038 vvm
(air volume/mediavolume/min), 0.052 vvm, and0.066 vvm forDays
1e5,Days5e10, andDays 11e13 (Dwyer Instruments,MichiganCity,
IN, USA), respectively. When proliferation was complete, wild
ginseng CMCs were subcultured every 13 days. Culture conditions
for the production stage to obtain secondary metabolites fromwild
ginseng CMCs were 1/2 MS media containing 3% brown sugar, cell
inoculum of 3.94 g/L (DCW), and 100mMmethyl jasmonate. The air
ﬂow rate was 0.06 vvm, and the cells were cultured for 7 d. Prolif-
eration and production culturewere performed in the same room in
the dark at a temperature of 21  1C. After proliferation and pro-
duction culture, biomass and major ginsenosides (Rb1, Rb2, Rc, Rd)
of wild ginseng CMCs were obtained. The cells were then heat-
treated in an extractor at 95C for 48 h to obtain rare ginsenosides.
During the heat treatment, major ginsenosides were converted to
Rg3, Rh2, Rg5, andRk1. Thebiomasswasharvested and freeze-dried.
2.3. HPLC analysis (chromatographic analysis of wild ginseng
CMCs)
An Agilent HPLC 1260 DAD system (Agilent Technologies, Santa
Clara, CA, USA) and Agilent Zorbax Eclipse plus C18 column
(4.6  100 mm, 3.5 mm, Agilent Technologies) were used for the
analysis of rare ginsenosides in wild ginseng CMCs. The detection
wavelength was 203 nm, the temperature of the column was 30C,
and the mobile phase was 0.05% triﬂuoroacetic acid in water and
0.05% triﬂuoroacetic acid in acetonitrile with a ﬂow rate of 1 mL/
min. Standards used for the analysis were ginsenoside 20(S)-Rg3,
ginsenoside 20(S)-Rh2, and a mixture of ginsenoside Rk1 and Rg5.
Solvents used for the analysis were acetonitrile, methanol, and
triﬂuoroacetic acid. Each standard was weighed and the concen-
tration was adjusted to 0.5 mg/mL using methanol. Freeze-dried
wild ginseng CMCs were ground to a ﬁne powder, and 80% of
methanol solutionwas added to 0.5 g of ground wild ginseng CMCs
to a volume of 10 mL. This solution was extracted for 2 h under
ultrasonicwaves, centrifuged, and ﬁltered through a 0.2-mmsyringe
ﬁlter (Toyo Roshi Kaisha, Ltd., Tokyo, Japan) for HPLC analysis.
2.4. Treatment of animals
Male SpragueeDawley rats weighing 250e300 g (Orient Bio,
Seongnam, Korea) were fasted overnight but given access to water
ad libitum. All animal experiments were approved by the Animal
Care Committee of Sungkyunkwan University School of Pharmacy,
Suwon, Korea (SUSP14-04) and performed in accordance with the
guidelines of National Institutes of Health (NIH publication No. 86-
23, revised 1985). To generate GalN-induced hepatitis model, rats
were injected intraperitoneally with 700 mg/kg of GalN dissolved
in phosphate-buffered saline. The dose of GalN was selected ac-
cording to previous reports [11,12]. There was no mortality in each
experimental group, and all animals were shown to induce hepa-
totoxicity after GalN administration. Wild ginseng CMCs were
suspended in distilled water and administered orally once a day for
2 wks and then 2 h prior to and 6 h after GalN injection. Animals
were randomly assigned among the following seven groups (n¼ 10
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CMCs (300 mg/kg)-treated control (wild ginseng CMCs þ control),
(3) vehicle-treated and GalN-treated (vehicle þ GalN), (4e6) wild
ginseng CMCs (75 mg/kg, 150 mg/kg, and 300 mg/kg)-treated and
GalN-treated (wild ginseng CMCs 75 mg/kg, 150 mg/kg, and 300
mg/kg þ GalN), and (7) silymarin (positive control, 50 mg/kg)-
treated and GalN-treated (silymarin 50 mg/kg þ GalN). Silymarin
was suspended in 10% Tween 80 saline and administered orally
once a day for 2 wks. The animals were euthanized under overdose
of ether 24 h after GalN injection, and blood samples were taken
from the inferior vena cava. The liver was isolated and used
immediately for the preparation of mRNA, which was stored
at75C for later analysis. A portion of the left lobe of the liver was
used for histologic analysis.
2.5. Serum aminotransferase activities
Serum alanine ALT and AST activities were determined with
standard spectrophotometric procedures using the ChemiLab ALT
and AST assay kits, respectively.
2.6. Histologic analysis
Liver tissues were removed from a portion of the left lobe, ﬁxed
immediately in10%neutral-buffered formalin, embedded inparafﬁn,
and sectioned at 5-mm thickness. Serial sections were stained with
hematoxylin and eosin for evaluation of portal inﬂammation, hepa-
tocellular necrosis, and inﬂammatory cell inﬁltration. Sections were
examined inablindedmannerunderanOlympusCKX41microscope
(Olympus Optical Co. Ltd., Tokyo, Japan).
2.7. Serum TNF-a, IL-6, and IL-10 levels
Serum levels of TNF-a, IL-6, and IL-10 were quantiﬁed at 24 h
after GalN injection using commercial mouse ELISA kits according
to the method described by Kang et al [13].
2.8. Preparation of protein extracts and Western blot immunoassay
Fresh liver tissue was isolated and homogenized in PRO- for
whole protein samples and in NE-PER for extraction of nuclear and
cytosolic protein samples, according to the manufacturer’s in-
structions. Protein concentrations were determined using the BCA
Protein Assay kit. Whole protein samples (20 mg) were used to
determine the content of COX-2 and HO-1, cytosolic protein sam-
ples (20 mg) were used to determine the content of Keap1, and
nuclear protein samples (10 mg) were used to determine the con-
tent of nuclear NF-kB/p65, phospho-cJun (p-cJun), and Nrf2. Protein
samples were separated by sodium dodecyl sulfate/polyacrylamideTable 1
Real-time RT-PCR primers used in study and the ampliﬁed product length
Gene Accession number Primer s
TNF-a NM_012675 Sense: A
Antisens
IL-6 NM_012589 Sense: A
Anti-sen
IL-10 NM_012854 Sense: G
Antisens
COX-2 NM_017232 Sense: TC
Antisens
HO-1 NM_012580 Sense: A
Antisens
b-Actin NM_031144 Sense: C
Antisens
COX, cyclooxygenase; HO, heme oxygenase; IL, interleukin; RT-PCR, reverse transcriptiogel electrophoresis and transferred to polyvinylidene diﬂuoride
membranes using the Semi-Dry Trans-Blot Cell. After the transfer,
the membranes were washed with 0.1% Tween 20 in Tris-buffered
saline and blocked for 1 h at room temperature with 5% (w/v) skim
milk powder in Tris-buffered saline. Blots were incubated overnight
at 4C with primary antibodies against COX-2 (1:4,000), HO-1
(1:4,000), Keap1 (1:4,000), NF-kB/p65 (1:4,000), p-cJun (1:4,000),
and Nrf2 (1:2,000). On the following day, the blots were incubated
with the appropriate secondary antibodies and detected using an
enhanced chemiluminescence detection system according to the
manufacturer’s instructions. Immunoreactive bands were evalu-
ated densitometrically with ImageQuant TL software (GE Health-
care, Piscataway, NJ, USA). Signals were normalized to that achieved
with antibodies to b-actin (1:4,000) for whole and cytosolic pro-
teins, or lamin B1 (1:10,000) for nuclear proteins.
2.9. Total RNA extraction and real time-polymerase chain reaction
For mRNA analysis, total RNA was extracted from liver tissue of
rats in the different treatment groups using RNAiso Plus, and cDNA
was synthesized using a reverse transcription reaction. The cDNA
was ampliﬁed using real-time polymerase chain reaction with a
thermocycler and the SYBR Green detection system. The ampliﬁ-
cation cycling conditions were as follows: 45 cycles of 30 s at 94C,
30 s at 56C, and 30 s at 72C for TNF-a and HO-1; 32 cycles of 30 s
at 94C, 45 s at 58C, 30 s at 72C for IL-6; 45 cycles of 30 s at 94C,
30 s at 64C, and 30 s at 72C for IL-10; 45 cycles of 30 s at 94C, 30 s
at 65C, and 30 s at 72C for COX-2; and 45 cycles of 30 s at 94C, 30
s at 62C, and 30 s at 72C for b-actin. The gene-speciﬁc primers
used are listed in Table 1. mRNA expression levels were normalized
to the expression level of b-actin and analyzed with respect to the
average of all delta Ct values in each sample using the cycle
threshold (Ct) method. All samples were run in duplicate to ensure
ampliﬁcation integrity.
2.10. Statistical analysis
All results are presented as mean  standard deviation. The
overall signiﬁcance of the data was analyzed with one-way analysis
of the variance. Differences between the groups were considered
signiﬁcant at p < 0.05 with the appropriate Bonferroni correction
made for multiple comparisons.
3. Results
3.1. Qualitative and quantitative analysis of wild ginseng CMCs
Wild ginseng CMCs were ultrasonically extracted and analyzed
through HPLC. The analyzed chromatogram is as shown in Fig. 1.equences (50e30) Product length
GA ACA GCA ACT CCA GAA CAC CCT 148
e: ATC TCG GAT CAT GCT TTC CGT GCT
TA TAC CAC TTC ACA AGT CGG 151
se: GGC AAA TTT CCT GGT TAT ATC C
AC CAG CTG GAC AAC ATA CT 143
e: GAG GGT CTT CAG CTT CTC TC
C AGT ATC AGA ACC GCA TTG CCT 149
e: AGC AAG TCC GTG TTC AAG GAG GAT
AC AAG CAG AAC CCA GTC TAT GC 212
e: GGC CCA CGC ATA TAC CCG CTA CCT
TA CAA TGA GCT GCG TGT GGC 229
e: CAG GTC CAG ACG CAG GAT GGC
n-polymerase chain reaction; TNF-a, tumor necrosis factor alpha
Fig. 1. HPLC chromatogram of ginsenosides detected from the wild ginseng CMCs. Numbers on the HPLC chromatogram indicate: (1) ginsenoside 20(S)-Rg3, (2) ginsenoside 20(R)-
Rg3, (3) ginsenoside Rk1, (4) ginsenoside Rg5, (5) ginsenoside 20(S)-Rh2, and (6) ginsenoside 20(R)-Rh2. CMC, cambial meristematic cells. CMCs, cambial meristematic cells.
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end of production culture stage were not detected after heat
treatment, conﬁrming that all these major ginsenosides have
transferred to rare ginsenosides. Rare ginsenosides contained in
wild ginseng CMCs were isolated and identiﬁed, and each com-
pound was conﬁrmed through electrospray ionization-mass spec-
trometry and nuclear magnetic resonance. In the analysis
condition, compounds that were detected at 17.1 min, 17.7 min, 21.8
min, 22.3 min, 23.4 min, and 24.0 min were 20(S)-Rg3, 20(R)-Rg3,
Rk1, Rg5, 20(S)-Rh2, and 20(R)-Rh2, respectively. The contents of
Rg3, Rk1, Rg5, and Rh2 were conﬁrmed through their standard
compounds as shown in Table 2. To calculate the contents of Rk1
and Rg5, areas of the individual peaks of Rk1 and Rg5 were added.
Rg3 and Rh2 were detected as isomers of the S form and R form,
and their contents were calculated by summing the area of the
individual peaks. Contents of rare ginsenosides, such as Rg3, Rh2,
and Rk1 þ Rg3 in dry cell of wild ginseng CMCs were 25.5 mg/g,
13.0 mg/g, and 29.0 mg/g, respectively. Rare ginsenosides are re-
ported to be contained in red ginseng in a small amount, but wild
ginseng CMCs produced high contents of rare ginsenosides. In
particular, 20(S)-Rh2, 20(R)-Rh2, Rk2, Rh3, and 20(S)-PPD, which
are rarely detected or are not contained in red ginseng, were highly
produced in wild ginseng CMCs.
3.2. Serum aminotransferase activities
Serum ALT and AST activities in the control were 37.1 17.6 U/L
and 75.6  30.3 U/L, respectively. At 24 h after GalN injection,
serum ALT and AST activities signiﬁcantly increased 4.8- and 6.8-
fold, respectively, compared with the control. These increases
were attenuated by treatment with wild ginseng CMCs at 75mg/kg,
150mg/kg, and 300mg/kg and silymarin at 50mg/kg.Wild ginseng
CMCs alone (300 mg/kg) did not affect serum aminotransferase
activities (Fig. 2A).Wild ginseng CMCs at 300mg/kgwas selected as
the optimally effective dose for evaluating the molecular mecha-
nisms by which wild ginseng CMCs attenuate GalN-induced he-
patic injury.
3.3. Histologic analysis
The histologic features of livers from control animals indicated
normal liver lobular architecture and cell structure (Fig. 2B).Table 2
Analysis of ginsenosides content (mg/g, DCW) of wild ginseng CMCs
Rare ginsenosides Rg3 Rk1 þ Rg5 Rh2 Total content
Content (mg/g, DCW) 25.5 29.0 13.0 67.5
CMCs, cambial meristematic cells; DCW, dry cell weightHowever, livers exposed to GalN showed obvious broad hemor-
rhagic necrosis, extensive areas of portal inﬂammation, and a
moderate increase in inﬂammatory cell inﬁltration. These patho-
logic alterations were ameliorated in animals that were treated
with wild ginseng CMCs.3.4. Cytokine levels
The serum level and hepatic mRNA expression of the proin-
ﬂammatory cytokine TNF-a in the GalN-treated group were
approximately 3.1- and 8.0-fold higher than that in the control
group, respectively (Fig. 3A). Similarly, the serum level and hepatic
mRNA expression of IL-6 in the GalN-treated group were approxi-
mately 13.5- and 12.2-fold higher than that in the control group,
respectively. These changes were attenuated by wild ginseng CMCs
(Fig. 3B). As shown in Fig. 3C, the serum level and hepatic mRNA
expression of the anti-inﬂammatory cytokine IL-10 increased 4.5-
and 3.1-fold at 24 h after GalN injection, respectively. These
changes in IL-10 expression were augmented by wild ginseng
CMCs.3.5. Hepatic COX-2 and HO-1 protein and mRNA expression
The levels of hepatic COX-2 protein andmRNA expression in rats
in the GalN groupwere approximately 8.2- and 4.1-fold higher than
that in the control group, respectively. The increased expression of
COX-2 mRNA and protein expression was attenuated by wild
ginseng CMCs (Fig. 4A). Fig. 4B shows that levels of hepatic HO-1
protein and mRNA expression increased 1.8- and 2.0-fold after
GalN injection compared with those of the control. These increases
were augmented by wild ginseng CMCs.3.6. Nuclear translocation of NF-kB, p-cJun, and Keap1/Nrf2
Nuclear levels of NF-kB/p65, p-cJun, and Nrf2, and the cytosolic
level of Keap1 were measured using immunoblot analysis (Fig. 5).
At 24 h after GalN injection, the nuclear level of NF-kB/p65
increased 4.5-fold compared with that of the control, whereas the
cytosolic level of NF-kB/p65 decreased compared with that of the
control. In the GalN-treated group, the nuclear protein level of
p-cJun increased 2.3-fold compared with the control. Wild ginseng
CMCs attenuated these changes in the levels of nuclear and cyto-
solic NF-kB/p65 but did not affect the level of nuclear p-cJun
(Fig. 5A, B). At 24 hours after GalN injection, the nuclear level of
Nrf2 increased 2.7-fold over the control, whereas the cytosolic level
of Keap1 decreased. Wild ginseng CMCs augmented the increase in
the nuclear level of Nrf2 and attenuated the decrease in the cyto-
solic level of Keap1 (Fig. 5C, D).
Fig. 2. Effects of wild ginseng CMCs on serum ALT, AST levels (A) and histological changes (B) in the rat liver after GalN (700 mg/kg) injection (original magniﬁcation 400). All
values are means  SD of 10 rats per group. Rats received oral injection of vehicle or wild ginseng CMCs (75, 150, and 300 mg/kg) once daily for 2 wks and 2 h prior to and 6 h after
GalN (700 mg/kg) treatment. **p < 0.05, signiﬁcantly different from control group. yp < 0.05, yyp < 0.01, signiﬁcantly different from GalN group. Histological features of liver sections
stained with H&E at 24 h after GalN injection. Typical images were chosen from each experimental group (original magniﬁcation, 400). Arrow and arrowhead indicate hem-
orrhagic necrosis and inﬂammatory cell inﬁltration, respectively. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CMCs, cambial meristematic cells; H&E, hema-
toxylin and eosin; GalN, D-galactosamine; SD, standard deviation.
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P. ginseng is one of themost abundantly used herbalmedicines in
Korea, China, and Japan. Many studies have reported that P. ginseng
possesses antidiabetic, antihepatotoxic, antifatigue, antistress, and
blood pressure regulatory effects [14]. Wild ginseng, however, is
rarely available, and the price is very high owing to its rarity. In
addition, extensive efforts on quality control are required because
the contents of ginsenosides vary depending on the ginseng species
and cultivation environments [15]. To overcome these problems,
plant cell culture emerged as an attractive alternative. Various tis-
sue culture techniques are being used to produce large amounts of
wild ginseng with increased yield of ginsenosides in a relatively
shorter time [16]. However, it is often not commercially viable
because of the difﬁculties associated with culturing dediffer-
entiated plant cells on an industrial scale and stable material pro-
duction. To bypass the dedifferentiation step, some of us established
a technique of isolation and culture of innately undifferentiated
CMCs. The isolation of CMCs from selected P. ginseng species may
ensure a stable method to provide high contents of ginsenosides
and sustainable supply for therapeutic applications [10].
GalN is a highly speciﬁc hepatotoxic agent that induces liver
injury closely resembling viral hepatitis when given to rats.
Administration of GalN disrupts the permeability of the plasma
membrane, causing leakage of enzymes from the cell. In our study,
a signiﬁcant elevation of serum ALT and AST was detected after
GalN injection, and this increase was attenuated by treatment with
wild ginseng CMCs. Normal lobular architecture and cell structurewere observed in the control group, whereas increased hepato-
cellular necrosis, portal inﬂammation, and inﬂammatory cell inﬁl-
tration were observed in the liver section obtained from GalN-
treated animals. These pathologic changes were attenuated by
treatment with wild ginseng CMCs, suggesting that wild ginseng
CMCs may have a potential clinical application in the treatment of
liver disease.
The liver is an inﬂammatory organ, and inﬂammatory processes
contribute to a number of pathologic events. Kupffer cells, the
resident macrophages of the liver, preside in a strategic position
within the liver sinusoids. They interact with hepatocytes, leuko-
cytes, and various mediators from the gut and therefore represent
the ﬁrst line of defense against microorganisms crossing the gut
mucosal barrier and entering the portal circulation. Moreover,
activated Kupffer cells produce a number of signaling molecules
that promote inﬂammatory reactions and cause cell dysfunction
and enhanced expression of adhesion molecules in endothelial
cells. Stachlewitz et al [17] demonstrated the integral role of
Kupffer cells in inﬂammatory cell interactions after GalN injection.
Furthermore, the interaction of neutrophils with endothelial cells
and subsequent neutrophil inﬁltration are observed in GalN-
induced hepatic injury [18]. TNF-a is one of the key proin-
ﬂammatory cytokines involved in the responses that ultimately
result in liver failure [19]. TNF-a participates in necrotic, apoptotic,
and inﬂammatory pathways in GalN-induced hepatotoxicity. IL-6,
promptly and transiently produced in response to infections and
tissue injuries, contributes to host defense through the stimulation
of acute phase responses, hematopoiesis, and immune reactions. IL-
Fig. 3. Effects of wild ginseng CMCs (300 mg/kg) on levels of serum TNF-a and hepatic mRNA expression (A), and serum IL-10 and hepatic mRNA expression (B) after GalN (700 mg/
kg) treatment. All values are means  SD of 10 rats per group. *p < 0.05, **p < 0.01, signiﬁcantly different from control group. yp < 0.05, yyp < 0.01, signiﬁcantly different from GalN
group. CMCs, cambial meristematic cells; GalN, D-galactosamine; IL, interleukin; TNF-a, tumor necrosis factor alpha; SD, standard deviation
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critical role in the acute phase response in the liver [20]. In our
study, we found that the serum level and hepatic gene expression
of TNF-a and IL-6 increased after GalN injection, and that these
increases were attenuated by wild ginseng CMCs.Fig. 4. Effects of wild ginseng CMCs (300 mg/kg) on levels of hepatic COX-2 protein and mR
mg/kg) treatment. All values are means  SD of 10 rats per group. *p < 0.05, **p < 0.01, sign
GalNgroup. CMCs, cambial meristematic cells; COX-2, cyclooxygenase-2; GalN, D-galactosamCOX-2 plays a key role in the pathogenesis of inﬂammation and
its expression is markedly upregulated by inﬂammatory stimuli
leading to increased synthesis of prostanoids, which are potent
lipid inﬂammatory mediators, in inﬂamed tissues. A previous
report demonstrated that genetic overexpression of COX-2NA expression (A), and hepatic HO-1 protein and mRNA expression (B) after GalN (700
iﬁcantly different from control group. yp < 0.05, yyp < 0.01, signiﬁcantly different from
ine; HO-1, heme oxygenase-1; SD, standard deviation.
Fig. 5. Effects of wild ginseng CMCs (300 mg/kg) on hepatic levels of nuclear NF-kB (A), p-cJun (B), and Nrf2 (C), and cytosolic Keap1 (D) protein expression. All values are
means  SD of 10 rats per group. *p < 0.05, **p < 0.01, signiﬁcantly different from control group. yp < 0.05, yyp < 0.01, signiﬁcantly different from GalN group. CMCs, cambial
meristematic cells; GalN, D-galactosamine; Keap1, kelch-like ECH-associated protein 1; NF-kB, nuclear factor-kappa B; Nrf2, NF-E2-related factor 2; TNF, tumor necrosis factor.
J Ginseng Res 2015;39:376e383382accelerates endotoxin-induced inﬂammation and subsequent liver
damage [21]. Modulation of COX-2 expression is an effective
strategy for regulating inﬂammation in an animal model of GalN-
induced hepatic failure. We demonstrated increased mRNA and
protein expression of hepatic COX-2 in GalN-treated animals, which
was ameliorated by wild ginseng CMCs. These results indicate that
wild ginseng CMCs suppress GalN-induced production of proin-
ﬂammatory mediators at the transcriptional level.
Toll-like receptors (TLRs) represent a family of pattern recog-
nition receptors that are essential for infectious and inﬂammatory
disease states. In particular, hepatic TLR2 and TLR4 mRNA and
protein expression were increased in patients with hepatitis and
cirrhosis [22,23]. Recent investigations demonstrated that GalN-
induced hepatotoxicity in rat involved the increase of expression
of TLR2 and TLR4 mRNA [24]. Accumulating data have shown the
involvement of transcription factors such as NF-kB and AP-1 in the
ampliﬁcation of inﬂammatory response in animal models of GalN-
induced hepatotoxicity. NF-kB is a ubiquitous transcription factor,
and the functional importance of NF-kB in inﬂammation is based on
its ability to regulate the transcription of multiple inﬂammatory
genes, including TNF-a and COX-2 [25]. A signiﬁcant decrease in
hepatic NF-kB activation was noted in TLR4 knockout mice
compared to wild type mice following the induction of fulminant
hepatic failure by GalN/lipopolysaccharide (LPS). AP-1 is a group of
dimeric transcription factors consisting of cJun, cFos, activating
transcription factor, andmusculoaponeurotic ﬁbrosarcoma, and the
combination of proteins in the AP-1 complex affects its DNA
binding activity. The TNF-a gene contains a cJun binding site in its
promoter. Mitogen-activated protein kinases phosphorylation by
stimulation of macrophage TLR4 activates the cJun, which subse-
quently promotes synthesis of proinﬂammatory mediators [26]. In
our study, elevated nuclear NF-kB/p65 and p-cJun protein levels
were observed in GalN-treated animals. Wild ginseng CMCs
reduced the increased nuclear level of NF-kB/p65 protein, but did
not affect the level of nuclear p-cJun protein. These results suggestthat wild ginseng CMCs inhibit the transactivation of NF-kB. Un-
fortunately, we did not ﬁnd a way to induce TLR2 and TLR4 mRNA
and protein expression in GalN-treated rats; however, this could be
a result of the differences in the injury models used by our group
(700 mg/kg GalN) and other groups (800 mg/kg GalN or 800 mg/kg
GalN þ 40 mg/kg LPS) [27]. Further investigations are needed to
elucidate the role of TLRs in GalN-induced hepatotoxicity.
A proper balance between pro- and anti-inﬂammatory re-
sponses is essential for maintaining an adequate immune response
in GalN-induced liver injury, and the upregulation of anti-
inﬂammatory mediators by therapeutic agent(s) may be helpful
in hepatoprotection. IL-10 is an anti-inﬂammatory cytokine that
was initially identiﬁed as a product of T helper cells (Th2) and has
since been reported to be produced by Kupffer cells, implying a role
in the regulation of local immune responses in the liver sinusoids
[28]. IL-10 can suppress serum TNF-a, interferon-g, and IL-1 levels
and reduce the mortality induced by GalN/LPS [29]. In the present
study, wild ginseng CMCs augmented the GalN-induced increase in
serum IL-10 protein level and its mRNA expression.
HO-1 has been implicated in the cellular adaptive response
against stress conditions. The primary function of HO-1 is to
catabolize the oxidative degradation of heme into carbonmonoxide
(CO), free iron, and biliverdin, and the CO produced by its activity
exerts powerful anti-inﬂammatory and anti-apoptotic effects.
There is accumulating evidence for a critical role of HO-1 signaling
in the protection against several inﬂammatory diseases [30]. Pre-
vious reports demonstrated that pharmacologic induction of HO-1
has an anti-inﬂammatory effect in sterile inﬂammatory settings of
hepatic ischemia/reperfusion, and that genetic overexpression by
adenovirus gene transfer of HO-1 (Ad-HO-1) confers cytoprotection
[31]. Nrf2 is a transcription factor that promotes the transcription of
a series of cytoprotective genes in response to cellular stress. Under
basal conditions, Nrf2 is sequestered by Keap1 in the cytosol. In
response to stress, Nrf2 is released from Keap1 and translocates
into the nucleus, where it induces an array of cytoprotective genes
S.-J. Kim et al / Hepatoprotective effect of CMC 383as an adaptive response. Alam and Cook [32] demonstrated that,
upon activation, Nrf2 enters the nucleus where it binds to the ARE
in the HO-1 promoter region to trigger gene expression. During
acute liver injury, and independent of the toxicants that caused it,
Nrf2 plays a protective role by inducing antioxidant enzymes such
as NAD(P)H quinone oxidoreductase 1 (Nqo1), glutathione, and
many proteins involved in the repair of oxidized proteins, and by
attenuating the expression of inﬂammatory genes including IL-1b,
IL-6, and TNF-a [33]. Increased translocation of HO-1 and Nrf2 to
protect the liver has been documented in GalN-induced acute liver
injury [34]. In our study, rats treated with GalN showed a decrease
in cytosolic levels of Keap1, and an increase in the nuclear level of
Nrf2 and hepatic mRNA expression of HO-1. Treatment with wild
ginseng CMCs augmented the increase in nuclear Nrf2 level and
hepatic HO-1 mRNA expression, and attenuated the decrease in
cytosolic Keap1 levels. These results suggest that wild ginseng
CMCsmay reduce the inﬂammatory response that occurs after GalN
injection via the enhancement of Nrf2 nuclear translocation and
subsequent induction of HO-1.
In summary, our ﬁndings suggest that wild ginseng CMCs pro-
tect against GalN-induced acute liver injury. The mechanism of
action of wild ginseng CMCs appear to involve its ability to inhibit
overexpression of proinﬂammatory mediators and nuclear trans-
location of NF-kB, and to induce the Nrf2/HO-1 anti-inﬂammatory
pathway. Thus, we propose that wild ginseng CMCs are a potential
therapeutic medication for the prevention of acute liver injury in
clinical settings. Moreover, our ﬁndings may provide important
information for novel therapeutic approaches using natural plant
products from cultured multipotent cells.
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